Drugmakers begin vaccine trials

While CSL in Australia began pandemic vaccine trials two weeks ago, other drug companies are also gearing up. Reuters is reporting that Novartis is beginning tests of their pandemic vaccine. Sanofi will start trials soon and Glaxo and AstraZeneca will begin trials later this month.

One bit of good news burried in the article,

"Initially, all the manufacturers except MedImmune -- which uses a different process -- struggled with low yields when making swine flu vaccine, with most companies only getting about 30 percent of the usual yield of seasonal flu strains.

But that is starting to improve.

"We are higher than that (30 percent)," Sanofi's Rungeard said."

Read the full article here: http://www.reuters.com/article/swineFlu/idUSL459625620090804?feedType=RSS&feedName=swineFlu&virtualBrandChannel=10521&pageNumber=2&virtualBrandChannel=0